Literature DB >> 8655984

Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia.

A G Tsolaki1, R F Miller, A P Underwood, S Banerji, A E Wakefield.   

Abstract

The opportunistic fungal pathogen Pneumocystis carinii sp. f. hominis is a frequent cause of pneumonia in the immunocompromised host. Analysis of genetic variation among isolates of P. carinii sp. f. hominis from 12 human immunodeficiency virus (HIV)-infected persons with single and multiple episodes of P. carinii pneumonia was undertaken at the internal transcribed spacer (ITS) regions of the nuclear rRNA operon. In samples from 24 episodes of pneumonia, 10 different types of P. carinii sp. f. hominis were identified. More than 1 sequence type was observed in 8 samples, indicating that mixed infection with different types of P. carinii sp. f. hominis is not uncommon. In 4 of 7 patients with recurrent episodes of pneumonia, the sequence types observed at the second episode were different from those of the first, suggesting the occurrence of both reactivation of a previously acquired infection and reinfection from an exogenous source.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655984     DOI: 10.1093/infdis/174.1.141

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Magnetic bead capture eliminates PCR inhibitors in samples collected from the airborne environment, permitting detection of Pneumocystis carinii DNA.

Authors:  N Maher; H K Dillon; S H Vermund; T R Unnasch
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

2.  Genetic diversity of Pneumocystis carinii isolated from human immunodeficiency virus-positive patients in Turin, Italy.

Authors:  G Volpe; L Sbaiz; C Avanzini; P Caramello; D Savoia
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Heterogeneity and compartmentalization of Pneumocystis carinii f. sp. hominis genotypes in autopsy lungs.

Authors:  J Helweg-Larsen; B Lundgren; J D Lundgren
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Internal transcribed spacer regions of rRNA genes of Pneumocystis carinii from monkeys.

Authors:  J Y Hsueh; R P Bohm; P J Didier; X Tang; M E Lasbury; B Li; S Jin; M S Bartlett; J W Smith; C H Lee
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  Frequent in vitro recombination in internal transcribed spacers 1 and 2 during genotyping of Pneumocystis jirovecii.

Authors:  Jessica Beser; Per Hagblom; Victor Fernandez
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

Review 6.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

7.  Genotyping and coalescent phylogenetic analysis of Pneumocystis jiroveci from South Africa.

Authors:  Frans J L Robberts; Lynne D Liebowitz; Lynda J Chalkley
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Determination of copy number of rRNA genes in Pneumocystis carinii f. sp. hominis.

Authors:  X Tang; M S Bartlett; J W Smith; J J Lu; C H Lee
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

10.  Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.

Authors:  Aimable Nahimana; Meja Rabodonirina; Jannik Helweg-Larsen; Isabelle Meneau; Patrick Francioli; Jacques Bille; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.